Alik Farber

2 months ago | ejves.com | Jeffrey J. Siracuse |Endovascular Surgery |Alik Farber |Matthew T. Menard |Kenneth Rosenfield |Michael S. Conte | +8 more

aDivision of Vascular and Endovascular Surgery, Department of Surgery, Boston University Chobanian and Avedisian School of Medicine, Boston Medical Center, Boston, MA bDivision of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Boston, MA cSection of Vascular Medicine, Massachusetts General Hospital, Boston, MA dDivision of Vascular and Endovascular Surgery, University of California San Francisco, San Francisco, CA eDivision of Vascular and Endovascular Surgery, University of...

Dec 11, 2024 | ejves.com | Matthew T. Menard |Alik Farber |Gheorghe Doros |Emiliano Chisci |Leonardo C. Clavijo |Ahmed Kayssi | +7 more

Feb 13, 2024 | hmpgloballearningnetwork.com | Alik Farber

In this video, Dr. Alik Farber, from Boston Medical Center in Massachusetts, discusses his ISET 2024 presentation on how to best manage patients with chronic limb-threatening ischemia in the wake of the BEST-CLI and BASIL-2 randomized controlled trials. Dr. Farber was the National Principal Investigator of the BEST-CLI trial.